European Commission President Ursula von der Leyen holds a press convention following a telephone name assembly with Britain’s Prime Minister Boris Johnson, in Brussels, Belgium December 13, 2020.
Olivier Hoslet | Reuters
LONDON — The European Union is doubling its inventory of the Pfizer-BioNTech coronavirus vaccine, as considerations develop over its rollout throughout the 27 member nations.
The vaccine developed with the German biotech was the primary one to be authorized by European regulators and it has been administrated throughout the area since Dec. 27. However, the rollout has been uneven and the European Commission has been criticized for not shopping for extra of the vaccine.
The Commission has argued that it has a diversified portfolio of vaccine contracts, as requested by member states, totaling as much as 2.three billion doses from “the most promising candidates.”
“As you know we have right now access to 300 million doses of the BioNTech-Pfizer vaccine. Now the good news is: we have now agreed with BioNTech-Pfizer to extend this contract. With the new agreement we could purchase a total of up to an additional 300 million doses,” Ursula von der Leyen, the fee’s president, mentioned at a press convention on Friday.
This would imply that the EU is on monitor to obtain 600 million doses of this vaccine. Speaking to CNBC in December, Pfizer’s CEO dedicated to producing 1.three billion doses in complete throughout 2021, which might imply Europe would obtain nearly half its annual output.
Seventy-five million doses of the new order can be out there within the second quarter of 2021. The the rest can be delivered within the third and fourth quarters.
The Netherlands solely began inoculating its residents this week and purple tape has reportedly put France among the many prime laggards in distributing the jab.
According to the European Centre for Disease Prevention and Control, there have been greater than 15 million reported circumstances of the coronavirus within the area thus far.
European regulators authorized a second coronavirus vaccine on Wednesday. Moderna’s candidate is predicted to be out there to European residents within the coming days.
“Europe will have more than enough vaccines within a reliable timeframe and this illustrates that the path we have taken in the European union is the right one,” von der Leyen mentioned on Friday, rebuffing criticism.